Skip to main content

Advertisement

SpringerLink
Log in

Effects of Vitamin K2 and Risedronate on Bone Formation and Resorption, Osteocyte Lacunar System, and Porosity in the Cortical Bone of Glucocorticoid-Treated Rats

  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

The purpose of the present study was to examine the effects of vitamin K2 and risedronate on bone formation and resorption, the osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid (GC)-treated rats. Forty-nine female Sprague-Dawley rats, 3 months of age, were randomized into five groups according to the following treatment schedule: age-matched control, GC administration, and GC administration with concomitant administration of vitamin K2, risedronate, or vitamin K2 + risedronate. At the end of the 8-week experiment, classical bone histomorphometric analysis was performed, and the osteocyte lacunar system and porosity were evaluated on the cortical bone of the tibial diaphysis. GC administration decreased percent cortical bone area and increased percent marrow area as a result of decreased periosteal bone formation, and increased endocortical bone erosion, and increased cortical porosity. Vitamin K2 prevented a reduction in periosteal bone formation but did not affect percent cortical bone and marrow areas. Risedronate prevented a reduction in periosteal bone formation and an increase in endocortical bone erosion, resulting in prevention of alterations in percent cortical bone and marrow areas. Both vitamin K2 and risedronate increased osteocyte density and lacunar occupancy and prevented a GC-induced increase in cortical porosity. Vitamin K2 and risedronate had additive effects on osteocyte density and lacunar occupancy and a synergistic effect on cortical porosity. The present study showed the efficacy of vitamin K2 and risedronate for bone formation and resorption, the osteocyte lacunar system, and porosity in the cortical bone of GC-treated rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993–1000

    Article  PubMed  Google Scholar 

  2. van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777–787

    Article  PubMed  Google Scholar 

  3. Furuichi H, Fukuyama R, Izumo N, Fujita T, Kohno T, Nakamuta H, Koida M (2000) Bone-anabolic effect of salmon calcitonin on glucocorticoid-induced osteopenia in rats. Bio Pharm Bull 23:946–951

    CAS  Google Scholar 

  4. Hara K, Kobayasi M, Akiyama Y (2002) Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats. Bone 31:575–581

    Article  PubMed  CAS  Google Scholar 

  5. Iwamoto J, Seki A, Takeda T, Sato Y, Yamada H, Shen CL, Yeh JK (2006) Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid. Exp Anim 55:349–355

    Article  PubMed  CAS  Google Scholar 

  6. Iwamoto J, Seki A, Takeda T, Sato Y, Yamada H, Shen CL, Yeh JK (2006) Comparative effects of risedronate and calcitriol on cancellous bone in rats with glucocorticoid-induced osteopenia. J Nutr Sci Vitaminol 52:21–27

    Article  PubMed  CAS  Google Scholar 

  7. Nitta T, Fukushima T, Nakamuta H, Koida M (1999) Glucocorticoid-induced secondary osteopenia in female rats: a time course study as compared with ovariectomy-induced osteopenia and response to salmon calcitonin. Jpn J Pharmacol 79:379–386

    Article  PubMed  CAS  Google Scholar 

  8. Noa M, Mendoza S, Mas R, Mendoza N, Leon F (2004) Effect of D-003, a mixture of very high molecular weight aliphatic acids, on prednisolone-induced osteoporosis in Sprague-Dawley rats. Drugs R D 5:281–290

    Article  PubMed  CAS  Google Scholar 

  9. Ortoft G, Oxlund H (1996) Qualitative alterations of cortical bone in female rats after long-term administration of growth hormone and glucocorticoid. Bone 18:581–590

    Article  PubMed  CAS  Google Scholar 

  10. Tanaka Y, Nakamura T, Nishida S, Suzuki K, Takeda S, Sato K, Nishii Y (1996) Effects of a synthetic vitamin D analog, ED-71, on bone dynamics and strength in cancellous and cortical bone in prednisolone-treated rats. J Bone Miner Res 11:325–336

    Article  PubMed  CAS  Google Scholar 

  11. Saha S, Hayes WC (1977) Relations between tensile impact properties and microstructure of compact bone. Calcif Tissue Res 24:65–72

    Article  PubMed  CAS  Google Scholar 

  12. Currey JD (1979) Changes in the impact energy absorption of bone with age. J Biomech 12:459–469

    Article  PubMed  CAS  Google Scholar 

  13. Dickenson RP, Hutton WC, Stott JR (1981) The mechanical properties of bone in osteoporosis. J Bone Joint Surg Br 63:233–238

    PubMed  Google Scholar 

  14. Epstein S (2007) Is cortical bone hip? What determines cortical bone properties? Bone 41:S3–S8

    Article  PubMed  Google Scholar 

  15. Manolagas SC (2000) Corticosteroids and fractures: a close encounter of the third cell kind. J Bone Miner Res 15:1001–1005

    Article  PubMed  CAS  Google Scholar 

  16. Nawata H, Soen S, Takayanagi R, Tanaka I, Takaoka K, Fukunaga M, Matsumoto T, Suzuki Y, Tanaka H, Fujiwara S, Miki T, Sagawa A, Nishizawa Y, Seino Y (2005) Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab 23:105–109

    Article  PubMed  Google Scholar 

  17. Iwamoto J, Yeh JK, Takeda T (2003) Effect of vitamin K2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats. J Bone Miner Res 18:776–783

    Article  PubMed  CAS  Google Scholar 

  18. Power J, Noble BS, Loveridge N, Bell KL, Rushton N, Reeve J (2001) Osteocyte lacunar occupancy in the femoral neck cortex: an association with cortical remodeling in hip fracture cases and controls. Calcif Tissue Int 69:13–19

    Article  PubMed  CAS  Google Scholar 

  19. Bell KL, Loveridge N, Power J, Rushton N, Reeve J (1999) Intracapsular hip fracture: increased cortical remodeling in the thinned and porous anterior region of the femoral neck. Osteoporos Int 10:248–257

    Article  PubMed  CAS  Google Scholar 

  20. Chen MM, Yeh JK, Aloia JF, Tierney JM, Sprintz S (1994) Effect of treadmill exercise on tibial cortical bone in aged female rats: a histomorphometry and dual energy X-ray absorptiometry study. Bone 15:313–319

    Article  PubMed  CAS  Google Scholar 

  21. Prakasam G, Yeh JK, Chen MM, Castro-Magana M, Liang CT, Aloia JF (1999) Effects of growth hormone and testosterone on cortical bone formation and bone density in aged orchiectomized rats. Bone 24:491–497

    Article  PubMed  CAS  Google Scholar 

  22. Shen V, Birchman R, Liang XG, Wu DD, Lindsay R, Dempster DW (1997) Prednisolone alone, or in combination with estrogen or dietary calcium deficiency or immobilization, inhibits bone formation but does not induce bone loss in mature rats. Bone 21:345–351

    Article  PubMed  CAS  Google Scholar 

  23. Hauschka PV, Lian JB, Cole DEC, Gundberg CM (1989) Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 69:990–1047

    PubMed  CAS  Google Scholar 

  24. Koshihara Y, Hoshi K (1997) Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res 12:431–438

    Article  PubMed  CAS  Google Scholar 

  25. Shearer MJ (1995) Vitamin K. Lancet 345:229–234

    Article  PubMed  CAS  Google Scholar 

  26. Vermeer C, Jie KSG, Knapen MHJ (1995) Role of vitamin K in bone metabolism. Annu Rev Nutr 15:1–22

    Article  PubMed  CAS  Google Scholar 

  27. Tabb MM, Sun A, Zhou C, Grun F, Errandi J, Romero K, Pham H, Inoue S, Mallick S, Lin M, Forman BM, Blumberg B (2003) Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem 278:43919–43927

    Article  PubMed  CAS  Google Scholar 

  28. Kobayashi M, Hara K, Akiyama Y (2004) Effects of vitamin K2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet. Bone 35:1136–1143

    Article  PubMed  CAS  Google Scholar 

  29. Otomo H, Sakai A, Ikeda S, Tanaka S, Ito M, Phipps RJ, Nakamura T (2004) Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2. J Bone Miner Metab 22:404–414

    Article  PubMed  CAS  Google Scholar 

  30. Shiraishi A, Higashi S, Masaki T, Saito M, Ito M, Ikeda S, Nakamura T (2002) Comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis. Calcif Tissue Int 71:69–79

    Article  PubMed  CAS  Google Scholar 

  31. Rogers MJ, Frith JC, Luckman SP, Coxon FR, Benford HL, Monkkonen J, Auriola S, Chilton KM, Russell RG (1999) Molecular mechanism of action of bisphosphonate. Bone 24(5 Suppl):73S–79S

    Article  PubMed  CAS  Google Scholar 

  32. Iwata K, Li J, Follet H, Phipps RJ, Burr DB (2006) Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia. Bone 39:1053–1058

    Article  PubMed  CAS  Google Scholar 

  33. Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T (1999) Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104:1363–1374

    Article  PubMed  CAS  Google Scholar 

  34. Giuliani N, Pedrazzoni M, Negri G, Passeri G, Impicciatore M, Girasole G (1998) Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo. Bone 22:455–461

    Article  PubMed  CAS  Google Scholar 

  35. Im GI, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS (2004) Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 25:4105–4115

    Article  PubMed  CAS  Google Scholar 

  36. von Knoch F, Jaquiery C, Kowalsky M, Schaeren S, Alabre C, Martin I, Rubash HE, Shanbhag AS (2005) Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. Biomaterials 26:6941–6949

    Article  CAS  Google Scholar 

  37. Idris AI, Rojas J, Greig IR, Van’t Hof RJ, Ralston SH (2008) Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro. Calcif Tissue Int 82:191–201

    Article  PubMed  CAS  Google Scholar 

  38. Orriss IR, Utting JC, Key ML, Brandao-Burch A, Colston K, Arnett TR (2007) Zoledronate potently inhibits the growth, function and survival of normal rat osteoblasts. Calcif Tissue Int 80(Suppl 1):S84

    Google Scholar 

  39. Currey JD (2003) The many adaptations of bone. J Biomech 36:1487–1495

    Article  PubMed  CAS  Google Scholar 

  40. Igarashi M, Yogiashi Y, Mihara M, Takada I, Kitagawa H, Kato S (2007) Vitamin K induces osteoblast differentiation through pregnane X receptor-mediated transcriptional control of the Msx2 gene. Mol Cell Biol 27:7947–7954

    Article  PubMed  CAS  Google Scholar 

  41. Koshihara Y, Hoshi K, Okawara R, Ishibashi H, Yamamoto S (2003) Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture. J Endocrinol 176:339–348

    Article  PubMed  CAS  Google Scholar 

  42. Follet H, Li J, Phipps RJ, Hui S, Condon K, Burr DB (2007) Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading. Bone 40:1172–1177

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Sports Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan

    Jun Iwamoto, Hideo Matsumoto & Tsuyoshi Takeda

  2. Department of Neurology, Mitate Hospital, 3237 Yugeta, Tagawa, Fukuoka, 826-0041, Japan

    Yoshihiro Sato

  3. Metabolism Laboratory, Department of Medicine, Winthrop-University Hospital, 259 First Street, Mineola, NY, 11501, USA

    Xiaoqing Liu & James K. Yeh

Authors
  1. Jun Iwamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hideo Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tsuyoshi Takeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshihiro Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaoqing Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. James K. Yeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jun Iwamoto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iwamoto, J., Matsumoto, H., Takeda, T. et al. Effects of Vitamin K2 and Risedronate on Bone Formation and Resorption, Osteocyte Lacunar System, and Porosity in the Cortical Bone of Glucocorticoid-Treated Rats. Calcif Tissue Int 83, 121–128 (2008). https://doi.org/10.1007/s00223-008-9146-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-008-9146-1

Keywords

Search

Navigation